For many, the snowfall in the Beijing-Tianjin-Hebei region serves as a reminder of the changing seasons and the cyclical nature of nature. It is a time to reflect on the passage of time and the beauty of the world around us. As the snowflakes gently drift down from the sky, blanketing the region in a layer of white, there is a sense of peace and tranquility that descends upon the land.

(The Center Square) – Homeowners in the market for washers and dryers may have better-performing options to choose from in the near future due to a bill limiting the extent of energy efficiency mandates on laundry appliances passing the U.S. House. The Republican-led House Resolution 1612 , or Liberty in Laundry Act, would prohibit the Secretary of Energy from enforcing energy conservation standards for clothes washers or dryers that “are not cost-effective or technologically feasible.” Rep. Andy Ogles, R-Tenn., who introduced the legislation, said the move is a response to the “slew of woke, ‘environmental’ nonsense rulemaking attempts” by the Biden administration and U.S. Department of Energy. “I have spent much of my time in Congress fighting back the federal government’s vast overreach into the lives of hardworking Americans,” Ogles announced after the bill’s passage Tuesday. “Americans should be able to do their laundry in peace without the input of Big Brother.” Earlier this year, the DOE finalized new updated standards for residential clothes washers and dryers which aim to cut costs and pollution. It estimates the regulations will reduce nearly 71 million metric tons of carbon dioxide emissions–equivalent to the combined annual emissions of nearly 9 million homes–and up to $39 billion on Americans’ energy and water bills over the next 30 years. House Democrats opposed the legislation's passage, saying "absolutely no one" stands to benefit from the law and accused Republicans of trying to curry favor with special interest groups. "H.R. 7673 guts popular energy efficiency standards for laundry machines – standards that save Americans money on their utility bills and reduce dangerous greenhouse gas pollution at the same time," said Energy and Commerce Committee Ranking Member Frank Pallone, Jr., D-N.J. "These efficiency standards create certainty for manufacturers and they protect consumers from rising costs. And, in the case of these laundry machine standards, they also reduce water use – a benefit that could greatly aid drought-prone regions around the nation." But the less electricity and water laundry appliances use, the less effectively they tend to perform, according to an Oct. 2024 report by the Institute for Energy Research. “Historically, appliances meeting Energy Department standards have often underperformed and have higher costs,” the report stated. “The Biden-Harris administration is imposing a series of regulations that are raising appliance prices and compromising quality for homeowners.” Unless the bill is signed into law, laundry appliance makers have until March 2028 to comply with the new rules.Sigh. If you thought the people working for the federal government were adults, think again. The U.S. State Department held taxpayer-funded “therapy and listening sessions” for government employees after Donald Trump’s 2024 election victory. pic.twitter.com/b780zA1emK Donald Trump can't clean house fast enough. First, grow up. Second, What the actual...!?!?Third, @VivekGRamaswamy @elonmusk , @DOGE https://t.co/hTxMbvru1M pic.twitter.com/vYH8EELhsR This. This government needs restructuring. https://t.co/oZT9ClIJ9V God help us these folks r so soft https://t.co/v5Q7ElMINi They are toilet tissue soft. Taxpayer funded 🤬 https://t.co/CNQ8i8AFGi That's the worst part. We are not a serious people. https://t.co/oToJxMyHhJ The therapy should be finding a real job https://t.co/nd0lA15HhD Hopefully, after January 20th, they will. People this soft shouldn't be working with state dept. https://t.co/A2xMLjffmA If you need a safe space, you shouldn't work for the state department. you have GOT to be kidding on this..?? https://t.co/ckd8myQCQU Coddling adults. Waste of money. Go listen to a taxpayer of you want to help with grief counseling. https://t.co/4kcAlZsGIX Listen to taxpayers who can't buy groceries. Those are the real sad stories. An easy way to start improving the state of this government would be to fire anyone that took part in these sessions. https://t.co/2xhlRCOoJV A great start. Anybody that attended should be fired! https://t.co/vS5x9CdG5Z Govt employees “needing therapy” because their person wasn’t elected is alarming. Any person that lacks a certain level of social awareness and mental fortitude shouldn’t be allowed to hold office. https://t.co/eUyAgnwQbJ They need a wake up call. The whole Government might need to be razed and rebuilt from the ashes. Holy crap. Elon and Vivek have their work cut out for them. https://t.co/aglxEUid8I Every single person who attended needs to be fired. You can not serve the USG in a diplomatic capacity when you need THERAPY over the duly elected POTUS. No reasonable person would trust you to represent the country fairly. https://t.co/myA77Rbau7 That pretty much sums it up. That needs to come out of their pay. No way should taxpayers fund anything so partisan. (Unless they can show they had the same sessions after Biden victory) https://t.co/kes45UGvSF Exactly. Pay for your own therapy like everyone else. A perfect example why @DOGE needs to exist. https://t.co/t1pygRlKjm It's so sorely needed.The rapid expansion of NVIDIA's presence in Mainland China can be attributed to the increasing demand for its products and services in the region, driven by the growing adoption of AI technologies, data centers, gaming, and autonomous vehicles. The Chinese market has been a key driver of growth for NVIDIA, with the company's revenue from the region seeing a significant increase in the past few quarters.

Expert Ratings For Revolve Gr

Injured cornerback Riley Moss could return to Denver's lineup at CincinnatiCrosswalk Ecosystem Unveils Groundbreaking DeFinitivePAPER (Whitepaper) on Decentralized Finance (DeFi) introducing C8WARP Technology infused DEx Aggregator + Native Swap & Global On/Off Ramping Complete ServicesIn response to the criticisms, Country Garden has issued a statement addressing the issues raised in the report. The company expressed regret over the findings and acknowledged the need for improvement in its operations. Country Garden emphasized its commitment to upholding high standards of integrity and professionalism in all aspects of its business.

A British Columbia judge recently issued an interim injunction , blocking a B.C. physician from providing medically assisted death (MAiD) to a 53-year-old woman. Her MAiD application stated she was seeking MAiD for akathisia, characterized by restlessness, terror, agitation, inability to sit still and burning skin sensations. The woman’s own Alberta health-care providers concluded that she did not have an irremediable condition (a legislative requirement for MAiD) and that MAiD was not appropriate, but B.C. physicians approved her for MAiD via videoconferencing. Supporters of broad access to MAiD denounced the litigation as a manipulative “anti-choice” tactic aimed at restricting individual rights . They argue that courts have no role in what they call “medical decision-making.” As a result of the court’s intervention, the woman involved is still alive. We argue here, as two legal scholars and a medical practitioner involved in MAiD policy and litigation, that judicial oversight over MAiD practice is essential. Extraordinary powers MAiD is not like any medical treatment. Deciding whether a MAiD death is appropriate is not a standard exercise of medical judgment , whereby a physician determines what treatment should be offered based on a professional assessment of often complex symptoms. Instead, doctors are tasked with applying Criminal Code criteria, which exempt MAiD from the crimes of homicide and aiding suicide. Unlike standard “medical treatments,” the intended outcome is to end a life. Our MAiD law delegates extraordinary power to health-care practitioners, with only limited, post-factum review of cases by provincial review bodies such as the Ontario Office of the Chief Coroner and the Québec Commission on End-of-Life Care , and general reporting obligations to Health Canada . But this review and reporting only takes place after patients are already dead. Judges play a crucial role in ensuring that those exercising statutory power , as with MAiD, use it responsibly, and that they follow the rules. Advocates for broad access to MAiD seem primarily concerned that family members may deny loved ones access to death. We and others are worried that people may be pressured into accessing MAiD due to caregiver burnout or financial concerns or interests, or in despair. There is currently no real oversight to prevent this. MAiD proponents portray MAiD as primarily a question of autonomy. But this strategy is misleading and a sleight-of-hand. People live in social contexts , connected to families and other communities that have a meaningful impact on their lives and well-being. Many Canadians struggle to keep loved ones safe from suicide. As a society, we value their commitment and love, rather than labelling them as heartless “anti-choice activists .” Suicide prevention remains an important societal obligation, to which family members make vital contributions. Suicide-prevention guidelines of leading mental health centres such as the Centre for Addiction and Mental Health in Toronto emphasize how family members are key in identifying suicide risks of loved ones and in helping to prevent suicide . And contrary to what is often claimed, suicide and MAiD are not neatly distinguishable, particularly when there are mental health issues. . Judicial oversight When family members or others have reason to believe doctors exceeded their authority or were clearly unreasonable, the court is the appropriate arbiter. Much as some supporters of broad MAiD policies may want it, the law does not give doctors free rein to end patients’ lives based on their own judgment; they are required to meet the criteria set out by the Criminal Code . Offering MAiD outside of those criteria is a crime, albeit a crime that has been largely unenforceable in Canada because of the lack of transparency about MAiD practice , the vague nature of the access criteria and safeguards , and the stark lack of meaningful oversight. In Canada we rely on MAiD providers to police themselves and to self-report whether they have complied with the Criminal Code criteria. Ending a life is final, with no room for second thought or further evaluation. Judicial oversight before death occurs acts as a crucial safeguard, not a hindrance. Doctors who respect the law should have nothing to fear from judicial oversight. Clearly, Justice Simon Coval in the Vancouver case had serious concerns regarding Dr. Ellen Wiebe and Dr. Elizabeth Whynot’s MAiD assessments, which would have resulted in the woman’s death had the family not been able to obtain legal support to appeal to the court. Unlike in two earlier cases , the judge did not shield the names of the doctors from public view and stated that in the pressing circumstances of the case, judicial review of both the approval process and the approval itself could reasonably be considered. We should use this tragic situation to critically examine the frailties of our existing law. The requirement of two independent practitioners assessing MAiD eligibility was intended to be a safeguard against wrongful death. It becomes meaningless if patients can shop around for MAiD approvals after being turned down, in some cases repeatedly , and still get approved for MAiD. In the current B.C. case, the patient was not deemed to qualify for MAiD in her home province by her treating physicians, but approved for MAiD by out-of-province doctors apparently without in-person meeting and without review of their full medical history. Where one MAiD assessor effectively selects the other, as apparently in this case , the second assessor can hardly be considered independent. Read more: Assisted dying: Canada grapples with plans to extend euthanasia to people suffering solely from mental illness Michel Bureau, head of the Québec commission on end-of-life care, has already raised these concerns about MAiD practice last year. While proponents of expansion argue that patients have no choice but to look around or “shop” for assessors since there are insufficient health care providers willing to be involved , current statistics show that it takes in Ontario on average only 2.2 days to connect to a MAiD practitioner , which is faster than access to virtually any health-care service outside of emergency care . And even when it comes to emergency care, lack of quality emergency care appears to have driven at least one disabled Québecer to request MAiD . Litigation and MAiD Finally, advocates suggest that litigation isn’t the way to address these issues. Yet it was litigation that got us here , and an inadequate legislative response to litigation that has left us with a largely unregulated MAiD regime that is ending the lives of thousands of Canadians every year . It is precisely the role of courts to rein in potential abuses of power, especially where legislators appear to have abdicated their responsibility to do so. The courts have long served as the last stop for upholding the rule of law and arbitrating alleged abuses by those with power. And make no mistake, medical practitioners have enormous influence over individuals whose suffering leaves them vulnerable to subtle forms of coercion and influence . We strongly support the need for families to have recourse to the courts where they have reason to believe doctors have taken shortcuts or not followed the rules. Parliament has left glaring gaps in oversight in a MAiD regime that has become a cautionary tale of how not to proceed. Courts can play a role in filling the gap. Ramona Coelho co-authored this story. She is a family physician and Senior Fellow of Domestic and Health Policy at the Macdonald-Laurier Institute, and a member of the Ontario Chief Coroner’s Office Medical Assistance in Dying (MAiD) Death Review Committee.

Oddsmakers Do Not See the Minnesota Wild as a Stanley Cup Threat

Broadcom Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results and Quarterly DividendBilibili streamers, renowned for their gaming expertise and engaging commentary, have been quick to capitalize on this latest development. Through their live broadcasts, they have been showcasing the diverse range of monster abilities, providing valuable insights and strategies for navigating these treacherous encounters. Viewers have been treated to a fascinating display of skill and tactics as the streamers go head-to-head with these formidable foes.

A UCLA student is suing multiple California health care providers and hospitals for medical negligence, alleging she was wrongly diagnosed with gender dysphoria and then “fast-tracked onto the conveyor belt of irreversibly damaging” puberty blockers, cross-sex hormones and surgery, according to her lawsuit. Kaya Clementine Breen, 20, said she experienced sexual abuse as a young child, and by the time she was 11, she “began struggling with the thought of developing into a woman and began to believe that life would be easier if she were a boy,” according to her suit filed last week in Los Angeles County Superior Court. When she expressed this to her then-school counselor, the counselor told her “that she was transgender and called her parents to tell them the same.” Breen, who was also suffering from anxiety, depression and undiagnosed post-traumatic stress disorder, according to the lawsuit, was then taken by her parents to the Center for Transyouth Health and Development at Children’s Hospital Los Angeles, where she said she was diagnosed with gender dysphoria — the distress one can experience when their gender identity and birth sex are in conflict — and began to receive transition-related care at 12 years old. “This case is about a team of purported health care providers who collectively decided that a vulnerable girl struggling with complex mental health struggles and suffering from multiple instances of sexual abuse should be prescribed a series of life-altering puberty blockers and cross-sex hormones, ultimately, receive a double mastectomy at the age of 14,” Breen’s lawsuit states. Breen began receiving puberty-suppressing medication at 12, was prescribed cross-sex hormones from 13 to 19 and underwent a double mastectomy at 14, according to court documents, which stated that her “her mental health progressively declined” following these treatments. In an interview with NBC News on Thursday, Breen said, “In retrospect, I wish that somebody had suggested real, genuine therapy first, instead of gender-specific therapy, because really the only therapy that I received until much later was specifically focused on gender dysphoria, and didn’t connect my gender dysphoria to anything else.” Breen said she began to question her decision to transition after she started dialectical behavior therapy , a type of talk therapy that seeks to help those struggling with intense emotions, earlier this year. “I sort of started questioning my own gender identity and if I was doing this for the right reasons,” she said. The defendants in Breen’s lawsuit include Dr. Johanna Olson-Kennedy, an adolescent medicine physician specializing in gender-affirming care; Children’s Hospital Los Angeles; Dr. Scott Mosser, a plastic surgeon specializing in gender-affirming surgery; the Gender Confirmation Center of San Francisco; UCSF Health Community Hospitals; and psychotherapist Susan P. Landon. When asked to comment on the lawsuit, a spokesperson said the Center for Transyouth Health and Development at Children’s Hospital Los Angeles, where Olson-Kennedy works, has “provided high quality, age-appropriate, medically necessary care for more than 30 years.” “Treatment is patient- and family-centered, following guidelines from professional organizations such as the American Academy of Pediatrics, American Medical Association, and Endocrine Society. We do not comment on pending litigation; and out of respect for patient privacy and in compliance with state and federal laws, we do not comment on specific patients and/or their treatment,” the spokesperson said in an email, adding that “Dr. Olson-Kennedy is unavailable for comment.” In response to a request for comment, a spokesperson for the Gender Confirmation Center in San Francisco, where Mosser works, said there’s “no such thing as a rubber stamp patient interaction” at their health facility. “As healthcare providers, and in compliance with HIPAA considerations, we are unable to comment on specific protected health information or pending litigation,” the spokesperson added in their email, which also included a link to a statement from Mosser. Mosser’s statement , which appears to have been posted to the Gender Confirmation Center’s website last week, applauded the center as being “at the forefront of gender-affirming surgery, with the wellbeing of our patients as our highest priority.” “Our robust processes and protocols are designed to ensure that patients navigating our services fully understand the implications of the gender-affirming procedures they may choose to undergo as part of their transition,” Mosser stated. “We regularly hear from former patients sharing updates about the overwhelmingly positive impact these surgeries have had on their lives — messages that continue to arrive many years after their procedures.” UCSF Health Community Hospitals, which is named in the lawsuit, told NBC News that Saint Francis Memorial Hospital, where Breen was a patient in 2019, was not acquired by UCSF until August of this year. It had no further comment. Landon did not respond to a request for comment. Breen said she doesn’t believe the individual health providers named in her lawsuit “intentionally acted in poor faith,” but she alleged they were dismissive of her pre-existing mental health issues. When asked what she hopes to get from this lawsuit, Breen said she wants “some semblance of justice or change.” While she is seeking “financial reimbursement for the amount that this has cost me and my family,” she said, she most of all wants to “help dismantle the rumor that no one is ever fast-tracked into gender treatments.” A long list of major U.S. medical associations — including the American Academy of Pediatrics , the American Medical Association and the American Psychiatric Association — support transgender minors having access to transition-related care, like puberty blockers and cross-sex hormones, and have denounced state laws restricting such care. “There is strong consensus among the most prominent medical organizations worldwide that evidence-based, gender-affirming care for transgender children and adolescents is medically necessary and appropriate. It can even be lifesaving,” Dr. Moira Szilagyi wrote on the American Academy of Pediatrics website in August 2022, when she was the organization’s president. “The decision of whether and when to start gender-affirming treatment, which does not necessarily lead to hormone therapy or surgery, is personal and involves careful consideration by each patient and their family.” Gender-affirming care for minors can look different depending on the child’s age and circumstances. For young children, care may involve a new name or pronoun as opposed to physical changes. At the onset of puberty, children may begin puberty blockers to inhibit them from developing secondary sex characteristics like breasts or facial hair. Hormone therapy may come next, which would allow the teenager to physically develop into the gender matching their identity. Surgical gender-affirming care is rarely performed on minors, and these procedures are illegal in dozens of states, though California is not among them. Over the past few years, there have been several lawsuits filed in the U.S. and the U.K. by “detransitioners,” or those who transitioned genders and then transitioned back to their birth sex. A 21-year-old New York woman who had detransitioned sued Planned Parenthood and several individual health care providers in April claiming medical malpractice and a lack of informed consent, alleging the defendants rushed her into undergoing gender-affirming care as a minor. Research suggests that regretting treatment for gender dysphoria is “extremely rare,” according to the World Professional Association for Transgender Health, or WPATH. A survey conducted in 2015 by the National Center for Transgender Equality found that 8% of respondents detransitioned at some point in their life, with 62% of that group only detransitioning temporarily. Transition-related care for minors has been a divisive political issue, with Republicans in 26 states passing measures to ban or restrict gender-affirming care for minors in recent years, according to the Movement Advancement Project, an LGBTQ think tank. The Supreme Court is currently weighing a case challenging Tennessee’s ban on such care. The politics surrounding gender-affirming care for minors were also reportedly behind a decision by Olson-Kennedy, one of the defendants in Breen’s lawsuit, to delay publication of a study she conducted on the effects of puberty blockers. Olson-Kennedy told The New York Times in an article published in October that she didn’t publish the results, which found the medication did not improve the mental health of minors with gender dysphoria, because she feared the findings might fuel the types of political attacks that led to state bans on gender-affirming care.

Another aspect that makes Exa stand out is its privacy and security measures. In a time where data privacy is a growing concern, Exa ensures that user data is protected and kept confidential. By encrypting user information and adhering to strict privacy policies, Exa gives users peace of mind knowing that their data is safe and secure.One of the standout features of the Three-Dimensional World platform is its complete independence in development. Unlike many other low-code platforms that rely on third-party tools and frameworks, Three-Dimensional World has invested extensive time and resources into building and refining their platform from scratch. This level of dedication to self-sufficiency sets Three-Dimensional World apart from its competitors and ensures a high degree of customization and flexibility for users.

Gabriel, known for his solid defensive performances, has been a stalwart in the Arsenal backline this season. His absence raises questions about the team's defensive stability and who will step up to fill his shoes in the upcoming matches. Manager Mikel Arteta will undoubtedly be assessing his options carefully to ensure the team's defensive solidity is maintained in Gabriel's absence.HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today, on December 24, 2024, the approval from Health Canada for its Multiplo® Rapid TP/HIV Test (Multiplo® TP/HIV) to be rolled out across Canada, a critical point-of-care tool to address the health crises with HIV and syphilis in Canada. The single Reveal® TP (Syphilis) approval will follow soon after this more complex approval. The Multiplo® TP/HIV rapid test allows healthcare professional to accurately detect both HIV-1/2 and syphilis antibodieswith one sample using a simple finger prick that delivers results immediately. This easy-to-use and high-quality test can be used in any setting and does not need any special storage conditions. Making it the perfect solution for use in hospitals, doctor's offices and other settings and provides another important option in the Canadian market to help people know their status and get connected to treatment and care. "Our Multiplo® TP/HIV device is the fastest testing solutions for HIV-1/2 and Syphilis and has been used in various settings and markets (such as in Europe, Colombia etc) for years. The Health Canada Medical Device License for professional-use will immediately address critical gaps in healthcare settings at a fraction of the costs of conventional testing systems," said Hermes Chan, CEO of MedMira, a world leader in developing rapid diagnostics and technologies. "Together with REACH Nexus we aim to supply urban and remote communities across Canada, and with it provide access to a critical needed screening tool. This test will have a significant impact on the already stretched and overburdened health care system by providing a fast and cost-efficient screening method." Health Canada's licensure of the device is based on the results of a landmark clinical study in Alberta, co-led by Dr. Sean B. Rourke, director of REACH Nexus and a scientist with the MAP Centre for Urban Health Solutions at St. Michael's Hospital (Unity Health Toronto) and Dr. Ameeta Singh at the University of Alberta. "We urgently need more rapid testing options approved in Canada to reach the undiagnosed with HIV, syphilis and other blood-borne infections and sexually transmitted infections (STBBIs)," said Dr. Rourke, the director of REACH Nexus at MAP. "We are very excited about this ongoing partnership with MedMira and the critical implementation science work that went into getting this device approved and into the hands of healthcare professionals." Health Canada's approval of the Multiplo® TP/HIV rapid test couldn't come at a more urgent time. The latest data from the Public Health Agency of Canada, shows that new HIV diagnoses soared more than 35% from 2022 to 2023, with rates in Manitoba rising by more than 40%. In Saskatchewan, the rate of HIV was 19.4 per 100,000 people, more than three times the national rate. In 2022, there were 13,953 reported syphilis cases, with rates increasing by 109% compared to 2018, and with congenital syphilis cases seeing a 7% increase from 2021 and a 599% increase from 2018(1). With the rising cases, particularly in underserved and remote communities, the Multiplo® TP/HIV provides an essential testing device to help reach the undiagnosed living with HIV and/or syphilis. "These tests are essential amid the rising number of STBBIs and will have real-life impacts," said Dr. Rourke. "Not everyone has access to the testing they need for STBBIs because of health inequities, stigma and various forms of discrimination. MedMira's rapid test is a crucial tool in Canada - so everyone can have access to the testing they need." As part of Health Canada's review and authorization process, Dr. Rourke's team of researchers sourced funding and conducted the landmark studyworking closely with healthcare providers, provincial health ministry and laboratory agencies, community stakeholders, and people with lived experience. The study, conducted from 2020-2022, included over 1,500 participants from clinical settings in Edmonton and northern Alberta. The study found the Multiplo® TP/HIV test to be 100 per cent accurate in identifying HIV infection, and more than 98 per cent accurate in detecting syphilis. "Having more HIV rapid tests increases our chances of reaching people in Canada who have HIV and don't know it, and a very significant and increasing number of infectious and congenital syphilis cases" said Dr. Rourke. "This rapid, accessible test helps breakdown barriers that some people face so they can get tested so they know their status. It helps move closer to ending the HIV and syphilis epidemics in Canada." (1) https://www.canada.ca/en/public-health/services/publications/diseases-conditions/hiv-canada-surveillance-report-december-31-2022.html About REACH Nexus at MAP Centre for Urban Health Solutions REACH Nexus is an ambitious national research group working on how to address HIV, Hepatitis C, and other sexually transmitted and blood-borne infections (STBBIs) in Canada. Their focus is on reaching the undiagnosed, implementing and scaling up new testing options, strengthening connections to care, improving access to options for prevention (PrEP and PEP) and ending stigma. We work in collaboration and partnership with people living with HIV; community-based organizations; front-line service providers; healthcare providers and decision makers; public health agencies; researchers; business leaders; industry partners, and federal, provincial and regional policymakers.REACH Nexus is part of MAP Centre for Urban Health Solutions at St. Michael's Hospital, Unity Health Toronto, and is funded by the Canadian Institutes of Health Research. Follow us on Twitter, Instagram and Facebook. About MedMira MedMira is a leading developer and manufacturer of Rapid Vertical Flow® diagnostics. The Company's tests provide hospitals, labs, clinics, and individuals with instant disease diagnosis, such as HIV, Syphilis, Hepatitis, and SARS-CoV-2, in just three easy steps. The Company's tests are sold globally under the REVEAL®, REVEALCOVID-19®, Multiplo® and Miriad® brands. Based on its patented Rapid Vertical Flow® Technology, MedMira's rapid HIV test is the only one in the world to achieve regulatory approvals in Canada, the United States, China and the European Union. MedMira's corporate offices and manufacturing facilities are located in Halifax, Nova Scotia, Canada. For more information visit medmira.com . Follow us on Twitter and LinkedIn . This news release contains forward‐looking statements, which involve risk and uncertainties and reflect the Company's current expectation regarding future events, including statements regarding possible regulatory approval, product launch, future growth, and new business opportunities. Actual events could materially differ from those projected herein and depend on a number of factors including, but not limited to, changing market conditions, successful and timely completion of clinical studies, uncertainties related to the regulatory approval process, establishment of corporate alliances and other risks detailed from time to time in the company quarterly filings. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. MedMira Contact Markus Meile Chief Financial Officer MedMira Inc. ir@medmira.com REACH Nexus Contact Andrew Russell Senior Communications Specialist REACH Nexus - MAP Centre for Urban Health Solutions andrew.russell@unityhealth.to SOURCE: MedMira Inc. View the original on accesswire.com

A Missouri judge says a law banning surgery, medications for transgender minors is constitutionalRashford, a product of the Manchester United youth academy, has long been regarded as one of the brightest prospects in English football. With his blistering pace, keen eye for goal, and versatility in attack, the 24-year-old has established himself as a key player for both club and country. However, despite his undeniable talent, Rashford has struggled to consistently perform at his best in recent seasons, leading to growing concerns among the United hierarchy about his long-term future at the club.On the other side of the transfer speculation, Real Madrid is reportedly monitoring the situation of Manchester United defender Diogo Dalot. The 22-year-old Portuguese full-back has struggled to establish himself as a regular starter at Old Trafford since joining from Porto in 2018.